Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

Author： Edelman R.   Palmer K.   Russ K.G.   Secrest H.P.   Anna L. Becker J.   Bodison S.A.   Perry J.G.   Sills A.R.   Barbour A.G.   Luke C.J.   Hanson M.S.   Stover C.K.   Burlein J.E.   Bansal G.P.   Connor E.M.   Koenig S.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.7, 1999-02, pp. : 904-914

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccination against Lyme Disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses

By Chang Y.-F.   Novosol V.   McDonough S.P.   Chang C.-F.   Jacobson R.H.   Divers T.   Quimby F.W.   Shin S.   Lein D.H.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 540-548

Elsevier

Access to resources Recommend Favorite

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi

By Golde W.T.   Burkot T.R.   Piesman J.   Dolan M.C.   Capiau C.   Hauser P.   Dequesne G.   Lobet Y.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 435-441

Elsevier

Access to resources Recommend Favorite

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults

By Van Hoecke C.   Comberbach M.   De Grave D.   Desmons P.   Fu D.   Hauser P.   Lebacq E.   Lobet Y.   Voet P.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1620-1626

Elsevier

Access to resources Recommend Favorite

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine

By Jianneng M.   Hine P.M.   Clough E.R.   Fish D.   Coughlin R.T.   Beltz G.A.   Shew M.G.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1366-1374

Elsevier

Access to resources Recommend Favorite

Inducing immunological response to Borrelia burgdorferi using outer membrane protein A; for use as a Lyme disease oral recombinant vaccine

By Barbour A.G.   Luke C.J.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 436-436

Elsevier

Access to resources Recommend Favorite